# Efficacy of Botulinum Toxin Type A for Acute Acquired Comitant Esotropia: An Age-Stratified Two-Year Follow-Up Study

> **NCT06966999** · NA · COMPLETED · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 276 (actual)

## Conditions studied

- Acute Acquired Comitant Esotropia

## Interventions

- **PROCEDURE:** Botulinum Toxin Type A Injection [Botox]

## Key facts

- **NCT ID:** NCT06966999
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2023-01-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 276 (ACTUAL)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06966999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06966999, "Efficacy of Botulinum Toxin Type A for Acute Acquired Comitant Esotropia: An Age-Stratified Two-Year Follow-Up Study". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT06966999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*